137 related articles for article (PubMed ID: 22743616)
1. Keap1: one stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL.
Tian H; Zhang B; Di J; Jiang G; Chen F; Li H; Li L; Pei D; Zheng J
Cancer Lett; 2012 Dec; 325(1):26-34. PubMed ID: 22743616
[TBL] [Abstract][Full Text] [Related]
2. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
3. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.
Hayes JD; McMahon M
Trends Biochem Sci; 2009 Apr; 34(4):176-88. PubMed ID: 19321346
[TBL] [Abstract][Full Text] [Related]
4. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
Giudice A; Arra C; Turco MC
Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
[TBL] [Abstract][Full Text] [Related]
5. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
6. The Keap1-Nrf2-antioxidant response element pathway: a review of its regulation by melatonin and the proteasome.
Vriend J; Reiter RJ
Mol Cell Endocrinol; 2015 Feb; 401():213-20. PubMed ID: 25528518
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.
Niture SK; Jaiswal AK
Free Radic Biol Med; 2013 Apr; 57():119-31. PubMed ID: 23275004
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals.
Surh YJ; Kundu JK; Na HK
Planta Med; 2008 Oct; 74(13):1526-39. PubMed ID: 18937164
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis.
Niture SK; Jaiswal AK
J Biol Chem; 2011 Dec; 286(52):44542-56. PubMed ID: 22072718
[TBL] [Abstract][Full Text] [Related]
11. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism.
Tong KI; Kobayashi A; Katsuoka F; Yamamoto M
Biol Chem; 2006; 387(10-11):1311-20. PubMed ID: 17081101
[TBL] [Abstract][Full Text] [Related]
12. Insight into the intermolecular recognition mechanism between Keap1 and IKKβ combining homology modelling, protein-protein docking, molecular dynamics simulations and virtual alanine mutation.
Jiang ZY; Chu HX; Xi MY; Yang TT; Jia JM; Huang JJ; Guo XK; Zhang XJ; You QD; Sun HP
PLoS One; 2013; 8(9):e75076. PubMed ID: 24066166
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of granulocyte oxidative burst in Nrf2 signaling in cancer.
Jaganjac M
Indian J Med Res; 2010 May; 131():609-16. PubMed ID: 20516531
[TBL] [Abstract][Full Text] [Related]
15. Keap1 regulates inflammatory signaling in Mycobacterium avium-infected human macrophages.
Awuh JA; Haug M; Mildenberger J; Marstad A; Do CP; Louet C; Stenvik J; Steigedal M; Damås JK; Halaas Ø; Flo TH
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):E4272-80. PubMed ID: 26195781
[TBL] [Abstract][Full Text] [Related]
16. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex.
Lo SC; Hannink M
J Biol Chem; 2006 Dec; 281(49):37893-903. PubMed ID: 17046835
[TBL] [Abstract][Full Text] [Related]
17. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity.
Nioi P; Nguyen T
Biochem Biophys Res Commun; 2007 Nov; 362(4):816-21. PubMed ID: 17822677
[TBL] [Abstract][Full Text] [Related]
18. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta.
Lee DF; Kuo HP; Liu M; Chou CK; Xia W; Du Y; Shen J; Chen CT; Huo L; Hsu MC; Li CW; Ding Q; Liao TL; Lai CC; Lin AC; Chang YH; Tsai SF; Li LY; Hung MC
Mol Cell; 2009 Oct; 36(1):131-40. PubMed ID: 19818716
[TBL] [Abstract][Full Text] [Related]
19. INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
Niture SK; Jaiswal AK
Cell Death Differ; 2011 Mar; 18(3):439-51. PubMed ID: 20865015
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells.
Son YO; Pratheeshkumar P; Divya SP; Zhang Z; Shi X
J Biol Chem; 2017 May; 292(20):8315-8330. PubMed ID: 28330870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
